Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeFDAStimSite Receives FDA Approval: Saves Valuable Operating Time Making Surgery More Efficient and Safe

StimSite Receives FDA Approval: Saves Valuable Operating Time Making Surgery More Efficient and Safe

November 17, 2020

StimSite has received FDA approval reports Allotrope Medical.

StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation. Ureter identification is a critical step in safely advancing in operations such as hysterectomies and colon.

“Whether it is a gynecologic or colorectal operation, a significant portion of OR time is spent looking for the Ureter* and keeping it safe. StimSite provides surgeons with an elegant tool to help rapidly identify the ureter, keep it safe from harm, and promote the progression of a pelvic operation. It should be in the toolbox of every surgeon doing pelvic surgery,” commented Brian Dunkin MD, past president of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

lan Greenberg MD in Frisco, Texas was the first physician to use StimSite during both laparoscopic and robotic gynecologic procedures. He noted, “StimSite is extremely helpful when trying to find the Ureter, and enables the surgeon to save valuable operating time while making the surgery more efficient and safe.”

“With ureter injuries being top of mind for all surgeons operating in the pelvis, we are excited to be able to offer a technology that helps surgeons identify this important structure in a simple and elegant way,” said Albert Huang MD, Allotrope Medical’s Chief Executive Officer and the inventor of StimSite. “StimSite gives surgeons a new capability to their existing instruments; helping them to provide the best surgical experience for physician and patient alike.”

*Ureter identification is required in over 3 million operations performed every year in the U.S. These include common procedures such as hysterectomies, endometriosis ablations, and colon resections among others. Injury to ureters can have a significant impact on the patient’s hospitalization and overall quality of life. As a result, identification and protection of the ureters during an operation is paramount for all surgeons operating in the pelvis.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy